Cyntellect

San Diego, United States Founded: 1997 • Age: 29 yrs
Offers technology for cell analysis, purification, and processing.
Request Access

About Cyntellect

Cyntellect is a company based in San Diego (United States) founded in 1997. It operates as a B2B. Cyntellect has raised $48.81 million across 10 funding rounds from investors including Third Security and National Science Foundation. Cyntellect operates in a competitive market with competitors including Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $48.81 M (USD)

    in 10 rounds

  • Latest Funding Round
    $9 M (USD), Series E

    May 14, 2010

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Cyntellect

Cyntellect has successfully raised a total of $48.81M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $9 million completed in May 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series E — $9.0M
  • First Round

    (01 Apr 2005)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2010 Amount Series E - Cyntellect Valuation

investors

Mar, 2010 Amount Series E - Cyntellect Valuation

investors

Nov, 2009 Amount Series E - Cyntellect Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cyntellect

Cyntellect has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Third Security and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Late-stage venture capital is provided to US life sciences companies.
Founded Year Domain Location
A government-backed foundation providing seed-stage investments to support small businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cyntellect

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cyntellect

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cyntellect Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cyntellect

Cyntellect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Advanced flow cytometry systems are manufactured for research applications.
domain founded_year HQ Location
Compact flow cytometers for cell analysis are developed and provided.
domain founded_year HQ Location
Instruments for life science research are developed and marketed.
domain founded_year HQ Location
IVD platforms are developed to detect and target cancer cells.
domain founded_year HQ Location
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
domain founded_year HQ Location
Instrumentation for cell and protein analysis is developed and marketed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cyntellect

Frequently Asked Questions about Cyntellect

When was Cyntellect founded?

Cyntellect was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Where is Cyntellect located?

Cyntellect is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Cyntellect a funded company?

Cyntellect is a funded company, having raised a total of $48.81M across 10 funding rounds to date. The company's 1st funding round was a Series E of $15.5M, raised on Apr 01, 2005.

What does Cyntellect do?

Cyntellect offers technology for cell analysis, purification, and processing through advancing biotech innovations, life sciences, cell analysis, and purification technology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of Cyntellect?

Cyntellect's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.

Who are Cyntellect's investors?

Cyntellect has 2 investors. Key investors include Third Security, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available